ArticleSAGE open medicine2022
GC-MS biocomponents characterization and antibacterial potency of ethanolic crude extracts of
Article in SAGE open medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Phytochemical profiling and in vitro biological activities of Opuntia ficus-indica oil extracted by different methods.Scientific reports · 2026Article
- Biodegradable chitosan/PVA-based hydrogel incorporating green synthesized silver nanoparticles for wound healing applications.BMC chemistry · 2025Article
- Antibacterial Activity of PeruvianInternational journal of microbiology · 2025Article
- Exploring the potential of biosurfactants produced by fungi found in soil contaminated with petrochemical wastes.Scientific reports · 2024Article
- Article
- GC-MS analysis, molecular docking, and pharmacokinetic studies of Multidentia crassa extracts' compounds for analgesic and anti-inflammatory activities in dentistry.Scientific reports · 2024Review
- In silico pharmacokinetic and therapeutic evaluation ofIn silico pharmacology · 2024Article
- Elucidation of chemical profiles and molecular targets of Mondia whitei leave fractions bioactive as novel therapeutics: an in vitro and in silico assay.Journal, genetic engineering & biotechnology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The menace of antibacterial resistance among enteropathogenic bacteria continues to raise therapeutic management concerns within public health system. As a strategy toward alternative control of resistant pathogen proliferation, a folkloric plant (green tea leaves: Methods: The bioactive and biomolecular components of the plant's ethanol extract were characterized using gas chromatography-mass spectrometry. A preliminary in vitro susceptibility test of the extract against characterized multiple antibiotic-resistant potential diarrheagenic bacterial strains was done. Results: The result revealed an exponential increase in susceptibility with a distinctive unit component of the Conclusion: The
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.